PMID: 8612448Sep 1, 1995Paper

Simultaneous acute cerebral and pulmonary edema complicating diabetic ketoacidosis

Diabetes Care
M C Young

Abstract

To report on a child with diabetic ketoacidosis (DKA) who developed simultaneous acute cerebral edema (CE) and pulmonary edema (PE), required extracorporeal membrane oxygenation (ECMO), and yet survived without significant neurological or pulmonary handicap. A 3-year-old girl with DKA as the first manifestation of insulin-dependent diabetes mellitus (IDDM) sustained coincident acute CE and PE 9 h into therapy. The former responded to mannitol, but the latter matured into adult respiratory distress syndrome (ARDS) resistant to conventional management and requiring ECMO. CE, PE, and ARDS can complicate DKA. Survival without sequelae is possible with aggressive treatment.

Citations

Dec 2, 1999·Pediatric Neurology·C P MahoneyM DelAguila
Jan 7, 1999·Journal of Diabetes and Its Complications·W H HoffmanR W Bassali
Jul 3, 2004·Pediatric Emergency Care·Nicole Glaser, Nathan Kuppermann
May 1, 2008·Pediatric Critical Care Medicine : a Journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies·Daniel L Levin
Apr 9, 1999·Acta Paediatrica. Supplement·S J Brink
Jan 23, 2004·Archives of Disease in Childhood·D B DungerUNKNOWN LWPES
Jun 16, 2004·Experimental Lung Research·Laryssa L McCloudJohn D Catravas
Dec 17, 2015·Indian Journal of Pediatrics·Siddhnath SudhanshuVijayalakshmi Bhatia
Nov 23, 2005·Pediatric Clinics of North America·Nicole Glaser
May 10, 2006·Diabetic Medicine : a Journal of the British Diabetic Association·A N DixonS C Bain
May 16, 2020·Nature Reviews. Disease Primers·Ketan K DhatariyaGuillermo E Umpierrez
Sep 29, 2020·Frontiers in Medicine·Todd S IngAntonios H Tzamaloukas

❮ Previous
Next ❯

Related Concepts

Related Feeds

American Diabetes Association Journals

Discover the latest diabetes research published by the journals from the American Diabetes Association.

Autoimmune Diabetes & Tolerance

Patients with type I diabetes lack insulin-producing beta cells due to the loss of immunological tolerance and autoimmune disease. Discover the latest research on targeting tolerance to prevent diabetes.